Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Strategy
Filter     Order     Display # 
Date Item Title
06 Aug 2008 Lilly Sells its Greenfield, Indiana, Operations to Covance; Expands Existing Collaboration Between the Two Companies
13 Jul 2008 Novartis enters strategic partnership with Lonza to accelerate growth of biologics pipeline
09 Jul 2008 RENTSCHLER focuses on biotechnology and sells RENTSCHLER Pharma GmbH
16 Jun 2008 Strategic Realignment Streamlines Operations, Reduces Workforce
04 Jun 2008 Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
03 Jun 2008 MediGene Focuses its Strategy on Oncology and Immunology
30 May 2008 Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
28 May 2008 Lexicon Pharmaceuticals Implements Reorganization to Deploy Resources Toward Drug Development Pipeline
22 Apr 2008 Environmentally Responsible Site to Significantly Increase Company's Presence in China
10 Apr 2008 PDL BioPharma Declares $500 Million Special Cash Dividend and Announces Plan to Separate Its Biotechnology Operations From Its Antibody Humanization Royalty Assets
01 Apr 2008 Glenmark implements Business Re-organisation
05 Mar 2008 Pfizer Presents New Opportunities for Global Growth
04 Mar 2008 Astellas announces global management system and establishes global development functional headquarters
04 Mar 2008 PDL BioPharma Ends Sale Process for Company and Restructures to Focus on Antibody Discovery and Development
25 Feb 2008 GPC Biotech Announces Corporate Restructuringand Provides Pipeline Update
14 Feb 2008 TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
29 Jan 2008 Viventia Biotech To Explore Strategic Alternatives
28 Jan 2008 Nicholas Piramal and Pierre Fabre Laboratories sign agreement
13 Dec 2007 Novartis Launches Strategic Initiative to Improve Competitiveness in a Dynamically Changing Healthcare Environment
05 Dec 2007 Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
19 Nov 2007 Takeda Established a New Company in the U.S. for Therapeutic Antibody Research
15 Nov 2007 GPC Biotech Announces Corporate Restructuring
13 Nov 2007 Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
29 Oct 2007 AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
27 Oct 2007 Tapestry Announces Strategy to Focus on TPI 287 Clinical Program
12 Oct 2007 Karo Bio to focus its operations
10 Oct 2007 Amarin Announces Initiation of Cardiovascular Development Strategy
02 Oct 2007 PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
29 Sep 2007 Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
04 Sep 2007 AstraZeneca Enhances Clinical Research Capabilities in China With First Clinical Pharmacology Unit
29 Aug 2007 Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
29 Aug 2007 PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
24 Aug 2007 Company Implements Leadership Succession Plan
16 Aug 2007 NEOPHARM presents updated development projections for its drug candidates at Annual Shareholder Meeting
10 Aug 2007 Johnson & Johnson Statement on Civil Complaint Against The American National Red Cross and Commercial Licensees
09 Aug 2007 AVIBioPharma announces refocused clinical development strategy
07 Aug 2007 Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
07 Aug 2007 Novartis concerned Indian court ruling will discourage investments in innovation needed to bring better medicines to patients
03 Aug 2007 Boston Scientific Provides Strategic Update
02 Aug 2007 Reorganisation of Astellas European Business Functions
02 Aug 2007 Anadys Pharmaceuticals Announces Strategic Restructuring and Reports Second Quarter 2007 Financial Results
02 Aug 2007 Nuvelo Reduces Expenses and Realigns Organization To Focus on Programs Expected To Yield Nearest-Term Proof-of-Concept Data
01 Aug 2007 Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology
01 Aug 2007 Johnson & Johnson Plans to Improve Overall Cost Structure, While Continuing to Invest in Opportunities for Sustained Profitable Growth
21 Jul 2007 Kirin and Terumo announce a basic agreement on a business collaboration
 
<< Start < Prev 1 Next > End >>
Results 1 - 45 of 45

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Emerging Diabetes Drugs

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics